---
figid: PMC6695603__ijms-20-03821-g002
figlink: /pmc/articles/PMC6695603/figure/ijms-20-03821-f002/
number: F2
caption: PD-1/PD-L1 immune checkpoint in NSCLC. In NSCLC cells, the binding of PD-1
  and PD-L1 promotes T-cell tolerance and escape from host immunity. Immunotherapy
  targeting the PD-1/PD-L1 immune checkpoints has used to treat metastatic NSCLC.
  Pembrolizumab, nivolumab and cemiplimab are anti-PD-1 inhibitors, and atezolizumab,
  durvalumab and avelumab are anti-PD-L1 inhibitors.
pmcid: PMC6695603
papertitle: Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein
  (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell
  Lung Cancer (NSCLC).
reftext: Ping-Chih Hsu, et al. Int J Mol Sci. 2019 Aug;20(15):3821.
pmc_ranked_result_index: '179917'
pathway_score: 0.9344178
filename: ijms-20-03821-g002.jpg
figtitle: PD-1/PD-L1 immune checkpoint in NSCLC
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6695603__ijms-20-03821-g002.html
  '@type': Dataset
  description: PD-1/PD-L1 immune checkpoint in NSCLC. In NSCLC cells, the binding
    of PD-1 and PD-L1 promotes T-cell tolerance and escape from host immunity. Immunotherapy
    targeting the PD-1/PD-L1 immune checkpoints has used to treat metastatic NSCLC.
    Pembrolizumab, nivolumab and cemiplimab are anti-PD-1 inhibitors, and atezolizumab,
    durvalumab and avelumab are anti-PD-L1 inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRA
  - PDCD1
  - CD274
  - TRD
  - TRB
  - TRG
  - TCR
  - NSCLC tumor
genes:
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: NSCLC tumor
  source: MESH
  identifier: D009369
figid_alias: PMC6695603__F2
redirect_from: /figures/PMC6695603__F2
figtype: Figure
---
